Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G for ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY).
- Disclosed ownership: 5.4%.
- Date of event: 17 Mar 2026.
MILLENNIUM MANAGEMENT LLC - 17 Mar 2026 SCHEDULE 13G Report for ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- SPRY
- Shares outstanding
- 99,841,481 shares
- Disclosed Ownership
- 5,391,440 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Mar 2026, 16:18:45 UTC
- Date of event
- 17 Mar 2026
- Next filing
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 5.4% ownership in ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY) on 17 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Mar 2026, 16:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 5.4% | 5,391,440 | 0 | 5,391,440 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 5.4% | 5,391,440 | 0 | 5,391,440 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 5.4% | 5,391,440 | 0 | 5,391,440 | /s/ Israel A. Englander | Israel A. Englander |